Riskpilot← Back to searchSign inGet full accessLEGEMIDDELSERVICE AS
ASActiveOrg 982752744Essendrops Gate 3, 0368 OsloPublishing of journals and periodicals · NACE 5813Est. 20011 employees
Revenue 2024
NOK 8,2M
+5% vs 2023
EBITDA margin
1.9%
+113% vs 2023
Equity ratio
13.1%
Financial strength
Net profit 2024
NOK 30K
+1541% vs 2023
| Revenue | NOK 8,2M | +5% |
| EBITDA | NOK 156K | +113% |
| Net profit | NOK 30K | +1541% |
| Total assets | NOK 6,1M | +2% |
| Equity | NOK 801K | +4% |
| Employees | 1 | — |
Legal name
LEGEMIDDELSERVICE AS
Org number
982752744
Legal form
Aksjeselskap
NACE code
5813 · Publishing of journals and periodicals
Founded
3. januar 2001
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Å fungere som eier og serviceinstitusjon for datterselskapene felleskatalogen as, farmastat as og legemidler & samfunn as.
Address
Essendrops Gate 3, 0368 Oslo
Phone
+4791185603
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 440 | 6 614 | 6 337 | 7 854 | 8 239 |
| Staff expenses | −2 351 | −2 709 | −2 756 | −2 829 | −2 963 |
| EBITDA | 179 | 95 | 58 | 73 | 156 |
| Depreciation & amort. | −173 | −90 | −68 | −94 | −165 |
| EBIT | 7 | 5 | −11 | −20 | −8 |
| Net financials | 6 | 3 | 11 | 23 | 47 |
| Profit before tax | 13 | 8 | −0 | 2 | 38 |
| Tax | 3 | 2 | −0 | 1 | 8 |
| Net profit | 10 | 6 | −0 | 2 | 30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 184 | 7 061 | 6 346 | 6 042 | 6 135 |
| Equity | 764 | 770 | 770 | 771 | 801 |
| Long-term debt | 4 324 | 4 324 | 4 324 | 4 324 | 4 324 |
| Short-term debt | 1 096 | 1 968 | 1 253 | 947 | 1 010 |
| Total debt | 5 420 | 6 291 | 5 576 | 5 271 | 5 334 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20202024
Equity ratio
13.1%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
3.7%
This company
18.4%
Market median
-80% vs market
20202024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20202024
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20202024
Debt / equity
6.66×
This company
0.62×
Market median
-974% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LR Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
KB Chief Executive Officer | Chief Executive Officer | 2009 – 2022 |
KØ Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (12) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2026 | |
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (6) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Legemiddelindustrien
LEGEMIDDELSERVICE AS Board members of LEGEMIDDELSERVICE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karita Bekkemellem | Chief Executive Officer | 0 companies |
| Leif Rune Skymoen | Chief Executive Officer | 0 companies |
| Kjetil Østreng Evensen | Chief Executive Officer | 0 companies |
| Mario Klesse | Board of Directors | 0 companies |
| Guro Bjøntegaard | Board of Directors | 0 companies |
| Martin Wiliam George Haswell | Board of Directors | 0 companies |
| Emma Jayne Setter | Board of Directors | 0 companies |
| Sebastian Marcus Heckerodt | Board of Directors | 0 companies |
| Anne Merete Sveaass | Board of Directors | 0 companies |
| Cathrine Thomassen | Chairman | 0 companies |
| Andreea-Aurelia Mocofan | Board of Directors | 0 companies |
| Duarte Joao Lourinho Marchand | Board of Directors | 0 companies |
| Nina Therese Hovland | Board of Directors | 0 companies |
| Veronika Barrabès | Board of Directors | 0 companies |
| Britt Moe Flatla | Board of Directors | 0 companies |
| Andre Bregård | Chairman | 0 companies |
| Paul Waaler | Board of Directors | 0 companies |
| Sissel Lønning Andresen | Board of Directors | 0 companies |
| Jan Børge Jakobsen | Board of Directors | 0 companies |
| Morten Lofthus Tangnes | Board of Directors | 0 companies |
| Kirsti Nyhus | Board of Directors | 0 companies |